Advyzon Investment Management LLC Acquires Shares of 1,134 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Advyzon Investment Management LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 1,134 shares of the medical equipment provider’s stock, valued at approximately $561,000.

Several other institutional investors have also recently made changes to their positions in the company. AlphaCore Capital LLC lifted its holdings in shares of Intuitive Surgical by 4.2% in the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider’s stock worth $235,000 after acquiring an additional 18 shares during the last quarter. Accredited Investors Inc. lifted its holdings in shares of Intuitive Surgical by 1.9% in the 4th quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider’s stock worth $543,000 after acquiring an additional 19 shares during the last quarter. Second Line Capital LLC lifted its holdings in shares of Intuitive Surgical by 3.4% in the 4th quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider’s stock worth $302,000 after acquiring an additional 19 shares during the last quarter. Colonial Trust Co SC lifted its holdings in shares of Intuitive Surgical by 8.8% in the 4th quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider’s stock worth $128,000 after acquiring an additional 20 shares during the last quarter. Finally, Crown Wealth Group LLC lifted its holdings in shares of Intuitive Surgical by 4.8% in the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock worth $218,000 after acquiring an additional 20 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of several analyst reports. Citigroup restated a “buy” rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Barclays reduced their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. Truist Financial raised their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 23rd. Robert W. Baird reduced their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. Finally, Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, July 26th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $595.95.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $483.36 on Tuesday. The company has a market capitalization of $173.27 billion, a price-to-earnings ratio of 67.41, a price-to-earnings-growth ratio of 5.06 and a beta of 1.59. The company’s 50-day simple moving average is $522.89 and its two-hundred day simple moving average is $531.90. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the previous year, the firm earned $1.78 EPS. The company’s quarterly revenue was up 21.4% compared to the same quarter last year. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the transaction, the senior vice president owned 907 shares of the company’s stock, valued at $510,740.77. The trade was a 19.23% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,903 shares of company stock valued at $7,932,778 in the last 90 days. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.